Premium
The use of imipenem‐cilastatin in neonatal meningitis caused by Citrobacter diversus
Author(s) -
HaimiCohen Y,
Amir J,
Weinstock A,
Varsano I
Publication year - 1993
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1993.tb12744.x
Subject(s) - citrobacter , medicine , cilastatin , meningitis , neonatal meningitis , imipenem/cilastatin , imipenem , regimen , intensive care medicine , antibiotics , pediatrics , microbiology and biotechnology , enterobacteriaceae , antibiotic resistance , escherichia coli , biology , biochemistry , gene
Citrobacter diversus is a cause of severe meningitis in neonates and infants. It is unique in its propensity to produce brain abscesses that play an important role in the poor prognosis associated with this condition. The recommended therapeutic regimen of third‐generation cephalosporines, aminoglyco‐sides and trimethoprim‐sulfamethoxazole is usually disappointing. We describe the use of imipenem‐cilastatin in successfully treating Citrobacter diversus meningitis complicated by brain abscesses.